Although chemical Pin1 inhibitors elicit potent antitumor effects against several human cancers, their inhibitory impact on the tumorigenic capacity of CD44+CD133+ tumor-initiating Caco-2 cells was unknown. This evidence concerns the gene PROM1 and neoplasm.